Business Segments · Subtotal
Prescription Technology Solutions — Subtotal
McKesson Prescription Technology Solutions — Subtotal remained flat by 0.0% to $261M in Q4 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $261M to $261M. Over 2 years (FY 2024 to FY 2026), Prescription Technology Solutions — Subtotal shows an upward trend with a 11.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ1 2024
Last reportedQ4 2026May 8, 2026
How to read this metric
An increase indicates improved core profitability and operational performance within the technology business.
Detailed definition
This metric serves as an intermediate financial subtotal for the Prescription Technology Solutions segment, often repres...
Peer comparison
Similar to 'segment operating profit' or 'segment income' reported by competitors.
Metric ID:
mck_segment_prescription_technology_solutions_subtotalHistorical Data
12 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $208M | $203M | $205M | $219M | $117M | $253M | $244M | $261M | $261M | $261M | $261M | $261M |
| QoQ Change | — | -2.4% | +1.0% | +6.8% | -46.6% | +116.2% | -3.6% | +7.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -43.8% | +24.6% | +19.0% | +19.2% | +123.1% | +3.2% | +7.0% | +0.0% |
Range$117M – $261M
CAGR+8.6%
Avg YoY Growth+19.0%
Median YoY Growth+13.0%
Current Streak5 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's prescription technology solutions — subtotal?
- McKesson (MCK) reported prescription technology solutions — subtotal of $261M in Q4 2026.
- How has McKesson's prescription technology solutions — subtotal changed year-over-year?
- McKesson's prescription technology solutions — subtotal decreased by 0.0% year-over-year, from $261M to $261M.
- What is the long-term trend for McKesson's prescription technology solutions — subtotal?
- Over 2 years (2024 to 2026), McKesson's prescription technology solutions — subtotal has grown at a 11.8% compound annual growth rate (CAGR), from $835M to $1.04B.
- What does prescription technology solutions — subtotal mean?
- A subtotal of the segment's financial performance before final corporate adjustments.